Viewing Study NCT05549661

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:19 PM
Ignite Modification Date: 2026-05-13 @ 4:31 AM
Study NCT ID: NCT05549661
Status: RECRUITING
Last Update Posted: 2025-02-14
First Post: 2022-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Chronic Myelomonocytic Leukemia View
None Refractory Chronic Myelomonocytic Leukemia View
None Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified View
None Recurrent Atypical Chronic Myeloid Leukemia View
None Recurrent Myelodysplastic/Myeloproliferative Neoplasm View
None Refractory Myelodysplastic/Myeloproliferative Neoplasm View
Keywords: